Haemonetics | HAE - Cost Of Sales

Stock Price
63.83
Daily Change
1.59 2.55%
Monthly
-3.38%
Yearly
-2.55%
Q1 Forecast
59.29

Haemonetics reported $136.58M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cerus USD 23.42M 3.61M Dec/2024
Cooper Companies USD 464.2M 45.9M Sep/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Neogen USD 118.01M 3.79M Sep/2025
OraSure Technologies USD 22.84M 6.8M Sep/2024
Quidel USD 448.8M 1.21B Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
STAAR Surgical USD 16.86M 5.34M Sep/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 33.03M 24.58M Sep/2024
Teleflex USD 261.54M 199.84M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
US Physical Therapy USD 160.86M 2.63M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025